From: Methodological framework for radiomics applications in Hodgkin’s lymphoma
Non-R/R | R/R | Overall | |
---|---|---|---|
Age, years | |||
Median and range | 42 (19–66) | 33 (19–74) | 35 (19–74) |
Sex | |||
Male | 15 | 37 | 52 |
Female | 12 | 21 | 33 |
Target HL lesions, n | |||
Nodal | 121 | 227 | 348 |
Extra-nodal | 51 | 144 | 195 |
Bone | 47 | 89 | 136 |
Liver | 2 | 5 | 7 |
Lung | – | 24 | 24 |
Spleen | 2 | 24 | 26 |
Other | – | 2 | 2 |
Overall (nodal + extra-nodal) | 172 | 371 | 543 |
Mean lesions number ± standard deviation | 6 (± 6) | 6 (± 8) | 6 (± 7) |
Median lesions number, range | 4 (2–27) | 4 (2–40) | 4 (2–40) |